应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02256 和誉-B
已收盘 05-02 16:08:25
7.950
+0.280
+3.65%
最高
7.980
最低
7.540
成交量
208.00万
今开
7.600
昨收
7.670
日振幅
5.74%
总市值
53.90亿
流通市值
53.90亿
总股本
6.78亿
成交额
1,631万
换手率
0.31%
流通股本
6.78亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
和誉-B(02256)5月2日斥资238.15万港元回购30万股
智通财经 · 11:01
和誉-B(02256)5月2日斥资238.15万港元回购30万股
和誉-B(02256)4月30日斥资76.93万港元回购10万股
智通财经 · 04-30 10:57
和誉-B(02256)4月30日斥资76.93万港元回购10万股
和誉-B04月30日遭主力抛售16.3万元
市场透视 · 04-30 08:15
和誉-B04月30日遭主力抛售16.3万元
和誉-B(02256)4月28日斥资223.5万港元回购30万股
智通财经 · 04-28
和誉-B(02256)4月28日斥资223.5万港元回购30万股
和誉-B(02256):和誉医药于2025年AACR大会展示ABSK112(EGFRexon20ins)、ABSK131(PRMT5*MTA)等四项最新突破性临床前研究成果
智通财经 · 04-28
和誉-B(02256):和誉医药于2025年AACR大会展示ABSK112(EGFRexon20ins)、ABSK131(PRMT5*MTA)等四项最新突破性临床前研究成果
和誉-B:于2025年AACR大会展示ABSK112(EGFR exon20ins)等四项最新突破性临床前研究成果
格隆汇 · 04-28
和誉-B:于2025年AACR大会展示ABSK112(EGFR exon20ins)等四项最新突破性临床前研究成果
和誉-B(02256)4月25日斥资75.8万港元回购10万股
智通财经 · 04-25
和誉-B(02256)4月25日斥资75.8万港元回购10万股
和誉-B04月24日主力净流入160万元 散户资金抛售
市场透视 · 04-24
和誉-B04月24日主力净流入160万元 散户资金抛售
和誉-B(02256)4月23日耗资约38.5万港元回购5.3万股
智通财经 · 04-23
和誉-B(02256)4月23日耗资约38.5万港元回购5.3万股
和誉-B盘中异动 早盘急速上涨5.23%报7.440港元
市场透视 · 04-23
和誉-B盘中异动 早盘急速上涨5.23%报7.440港元
港股概念追踪|美国AACR 2025年会临近 机构关注创新药发展趋势(附概念股)
智通财经 · 04-23
港股概念追踪|美国AACR 2025年会临近 机构关注创新药发展趋势(附概念股)
和誉-B(02256)4月22日斥资141.19万港元回购20万股
智通财经 · 04-22
和誉-B(02256)4月22日斥资141.19万港元回购20万股
和誉-B04月22日主力净流入363万元 散户资金抛售
市场透视 · 04-22
和誉-B04月22日主力净流入363万元 散户资金抛售
和誉-B盘中异动 下午盘快速上涨5.26%
市场透视 · 04-22
和誉-B盘中异动 下午盘快速上涨5.26%
和誉-B(02256)4月16日斥资405.62万港元回购60万股
智通财经 · 04-16
和誉-B(02256)4月16日斥资405.62万港元回购60万股
和誉-B04月15日主力净流出170万元 散户资金买入
市场透视 · 04-15
和誉-B04月15日主力净流出170万元 散户资金买入
和誉-B04月14日主力净流入517万元 散户资金抛售
市场透视 · 04-14
和誉-B04月14日主力净流入517万元 散户资金抛售
和誉-B午前涨超6% 机构指公司年内开始有望迎来密集收获
新浪港股 · 03-11
和誉-B午前涨超6% 机构指公司年内开始有望迎来密集收获
港股异动 | 和誉-B(02256)盘中涨超5% 机构指公司年内开始有望迎来密集收获 目前现金充裕
智通财经 · 03-11
港股异动 | 和誉-B(02256)盘中涨超5% 机构指公司年内开始有望迎来密集收获 目前现金充裕
和誉-B盘中异动 股价大涨5.16%报7.740港元
市场透视 · 03-11
和誉-B盘中异动 股价大涨5.16%报7.740港元
公司概况
公司名称:
和誉-B
所属市场:
SEHK
上市日期:
--
主营业务:
和誉开曼有限责任公司是一家中国的临床阶段生物制药公司。该公司致力于发现及开发创新且差异化的小分子肿瘤疗法。该公司拥有两款核心候选产品ABSK011及ABSK091以及12款其他管线候选产品。ABSK011是一种有效的高选择性小分子成纤维细胞生长因子受体4(FGFR4)抑制剂。ABSK091是一种分子靶向候选产品,是FGFR亚型1、2及3的高效及选择性抑制剂。该公司的产品主要用于治疗肝细胞癌(HCC)、尿路上皮癌(UC)及胃癌(GC)。
发行价格:
--
{"stockData":{"symbol":"02256","market":"HK","secType":"STK","nameCN":"和誉-B","latestPrice":7.95,"timestamp":1746173305031,"preClose":7.67,"halted":0,"volume":2080000,"delay":0,"floatShares":678000000,"shares":678000000,"eps":0.04782528477652656,"marketStatus":"已收盘","change":0.28,"latestTime":"05-02 16:08:25","open":7.6,"high":7.98,"low":7.54,"amount":16307150,"amplitude":0.057366,"askPrice":7.97,"askSize":1000,"bidPrice":7.95,"bidSize":34000,"shortable":0,"etf":0,"ttmEps":0.04285312647348311,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746495000000},"marketStatusCode":5,"adr":0,"listingDate":1634054400000,"exchange":"SEHK","adjPreClose":7.67,"openAndCloseTimeList":[[1746149400000,1746158400000],[1746162000000,1746172800000]],"volumeRatio":0.793288,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02256/wiki","defaultTab":"wiki","newsList":[{"id":"2532812587","title":"和誉-B(02256)5月2日斥资238.15万港元回购30万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2532812587","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532812587?lang=zh_cn&edition=full","pubTime":"2025-05-02 19:01","pubTimestamp":1746183667,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和誉-B(02256)发布公告,于2025年5月2日,该公司斥资238.15万港元回购30万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289064.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02256","LU2488822045.USD"],"gpt_icon":0},{"id":"2531657080","title":"和誉-B(02256)4月30日斥资76.93万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531657080","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531657080?lang=zh_cn&edition=full","pubTime":"2025-04-30 18:57","pubTimestamp":1746010625,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和誉-B(02256)发布公告,该公司于2025年4月30日斥资76.93万港元回购10万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288518.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU2488822045.USD","02256"],"gpt_icon":0},{"id":"2531083318","title":"和誉-B04月30日遭主力抛售16.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531083318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531083318?lang=zh_cn&edition=full","pubTime":"2025-04-30 16:15","pubTimestamp":1746000920,"startTime":"0","endTime":"0","summary":"04月30日, 和誉-B股价跌0.13%,报收7.67元,成交金额1653.6万元,换手率0.32%,振幅2.47%,量比0.61。和誉-B今日主力资金净流出16.3万元,连续4日净流出,上一交易日主力净流出38万元。该股近5个交易日上涨0.52%,主力资金累计净流出88.3万元;近20日主力资金累计净流出2860.0万元,其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170414a6ce9888&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170414a6ce9888&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02256","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2530474875","title":"和誉-B(02256)4月28日斥资223.5万港元回购30万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2530474875","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530474875?lang=zh_cn&edition=full","pubTime":"2025-04-28 19:10","pubTimestamp":1745838637,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和誉-B(02256)发布公告,于2025年4月28日斥资223.5万港元回购30万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286578.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02256","LU2488822045.USD"],"gpt_icon":0},{"id":"2530493368","title":"和誉-B(02256):和誉医药于2025年AACR大会展示ABSK112(EGFRexon20ins)、ABSK131(PRMT5*MTA)等四项最新突破性临床前研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2530493368","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530493368?lang=zh_cn&edition=full","pubTime":"2025-04-28 08:52","pubTimestamp":1745801542,"startTime":"0","endTime":"0","summary":"该等研究成果为ABSK131在MTAP纯合缺失的癌症中以单药或者联合治疗方案的临床开发提供了有力支持。此外, ABK-KRAS-1具有良好的成药性。因此ABK-KRAS-1可作为一款用于治疗携带 KRAS突变癌症的非常有前景的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286069.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","02256","BK1574","BK4188","BK1515","09939","MTA","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2530746734","title":"和誉-B:于2025年AACR大会展示ABSK112(EGFR exon20ins)等四项最新突破性临床前研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2530746734","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530746734?lang=zh_cn&edition=full","pubTime":"2025-04-28 08:02","pubTimestamp":1745798576,"startTime":"0","endTime":"0","summary":"格隆汇4月28日丨和誉-B(02256.HK)发布公告,其在2025年4月25日至4月30日于美国伊利诺伊州芝加哥举行的2025年美国癌症研究协会大会上以壁报的形式发布了四项最新突破性的临床前研究结果。该等研究成果包括EGFR exon20ins抑制剂 ABSK112、PRMT5*MTA抑制剂ABSK131以及pan-KRAS抑制剂ABK-KRAS-1,以及一项研究KRAS G12C抑制剂潜在耐药机制的研究成果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428080257a6cae3ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428080257a6cae3ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02256","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2530909573","title":"和誉-B(02256)4月25日斥资75.8万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2530909573","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530909573?lang=zh_cn&edition=full","pubTime":"2025-04-25 17:32","pubTimestamp":1745573549,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和誉-B(02256)发布公告,于2025年4月25日,该公司斥资75.8万港元回购10万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1285051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02256","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2529679851","title":"和誉-B04月24日主力净流入160万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529679851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529679851?lang=zh_cn&edition=full","pubTime":"2025-04-24 16:16","pubTimestamp":1745482575,"startTime":"0","endTime":"0","summary":"04月24日, 和誉-B股价涨3.15%,报收7.87元,成交金额3309万元,换手率0.62%,振幅4.98%,量比0.82。和誉-B今日主力资金净流入160万元,上一交易日主力净流出175万元。该股近5个交易日上涨10.20%,主力资金累计净流入302万元;近20日主力资金累计净流出2683万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424170031a6c6562b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424170031a6c6562b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02256","BK1161"],"gpt_icon":0},{"id":"2529574800","title":"和誉-B(02256)4月23日耗资约38.5万港元回购5.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2529574800","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529574800?lang=zh_cn&edition=full","pubTime":"2025-04-23 18:06","pubTimestamp":1745402798,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和誉-B(02256)公布,2025年4月23日耗资约38.5万港元回购5.3万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283198.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02256","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2529519620","title":"和誉-B盘中异动 早盘急速上涨5.23%报7.440港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529519620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529519620?lang=zh_cn&edition=full","pubTime":"2025-04-23 11:23","pubTimestamp":1745378580,"startTime":"0","endTime":"0","summary":"2025年04月23日早盘11时23分,和誉-B股票出现异动,股价大幅拉升5.23%。截至发稿,该股报7.440港元/股,成交量228.7万股,换手率0.34%,振幅3.68%。资金方面,该股资金流入976.604万港元,流出429.638万港元。和誉-B股票所在的生物技术行业中,整体涨幅为1.91%。该公司拥有两款核心候选产品ABSK011及ABSK091以及12款其他管线候选产品。ABSK091是一种分子靶向候选产品,是FGFR亚型1、2及3的高效及选择性抑制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423112300aa2c777b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423112300aa2c777b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1161","02256"],"gpt_icon":0},{"id":"2529516590","title":"港股概念追踪|美国AACR 2025年会临近 机构关注创新药发展趋势(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2529516590","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529516590?lang=zh_cn&edition=full","pubTime":"2025-04-23 09:50","pubTimestamp":1745373032,"startTime":"0","endTime":"0","summary":"2025 年美国癌症研究协会年会将于当地时间2025年4月25日-30日在美国芝加哥举办。本次AACR年会上国清院展示8项临床前研究成果,包括多个全球首创的双抗、多抗及ADC的首次亮相。长江生命科技:公司将在美国芝加哥举行的美国癌症研究协会2025年度年会上,展示研发中癌症疫苗临床前研究最新数据。相关研究摘要将于美国东部时间2025年4月11日发表于AACR官方期刊《Cancer Research》。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282904.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","YANG","00775","159992","BK1569","HSTECH","BK1574","BK4614","LU2488822045.USD","06978","02256"],"gpt_icon":1},{"id":"2529271375","title":"和誉-B(02256)4月22日斥资141.19万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2529271375","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529271375?lang=zh_cn&edition=full","pubTime":"2025-04-22 18:25","pubTimestamp":1745317516,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和誉-B(02256)发布公告,于2025年4月22日斥资141.19万港元回购股份20万股,每股回购价格为6.9-7.23港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282336.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","02256","BK1161"],"gpt_icon":0},{"id":"2529684325","title":"和誉-B04月22日主力净流入363万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529684325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529684325?lang=zh_cn&edition=full","pubTime":"2025-04-22 16:15","pubTimestamp":1745309710,"startTime":"0","endTime":"0","summary":"04月22日, 和誉-B股价涨3.36%,报收7.07元,成交金额6435万元,换手率1.35%,振幅7.31%,量比2.01。和誉-B今日主力资金净流入363万元,上一交易日主力净流出0万元。该股近5个交易日上涨2.93%,主力资金累计净流入664万元;近20日主力资金累计净流出4195万元,其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422170509a6c3899e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422170509a6c3899e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02256","BK1161"],"gpt_icon":0},{"id":"2529631674","title":"和誉-B盘中异动 下午盘快速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529631674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529631674?lang=zh_cn&edition=full","pubTime":"2025-04-22 13:31","pubTimestamp":1745299870,"startTime":"0","endTime":"0","summary":"2025年04月22日下午盘13时31分,和誉-B股票出现波动,股价大幅拉升5.26%。和誉-B股票所在的生物技术行业中,整体涨幅为5.14%。和誉-B公司简介:和誉开曼有限责任公司是一家中国的临床阶段生物制药公司。该公司拥有两款核心候选产品ABSK011及ABSK091以及12款其他管线候选产品。ABSK091是一种分子靶向候选产品,是FGFR亚型1、2及3的高效及选择性抑制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042213311094ddab1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042213311094ddab1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02256","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2527247000","title":"和誉-B(02256)4月16日斥资405.62万港元回购60万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2527247000","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527247000?lang=zh_cn&edition=full","pubTime":"2025-04-16 22:59","pubTimestamp":1744815577,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和誉-B(02256)发布公告,于2025年4月16日,该公司斥资405.62万港元回购60万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1279806.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02256","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2527610664","title":"和誉-B04月15日主力净流出170万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2527610664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527610664?lang=zh_cn&edition=full","pubTime":"2025-04-15 16:16","pubTimestamp":1744704975,"startTime":"0","endTime":"0","summary":"04月15日, 和誉-B股价跌0.56%,报收7.16元,成交金额2856万元,换手率0.58%,振幅7.22%,量比0.51。和誉-B今日主力资金净流出170万元,上一交易日主力净流入517万元。该股近5个交易日上涨13.05%,主力资金累计净流出756万元;近20日主力资金累计净流出1906万元,其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415171347a6bb0459&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415171347a6bb0459&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02256","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2527186921","title":"和誉-B04月14日主力净流入517万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2527186921","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527186921?lang=zh_cn&edition=full","pubTime":"2025-04-14 16:15","pubTimestamp":1744618550,"startTime":"0","endTime":"0","summary":"04月14日, 和誉-B股价涨5.42%,报收7.20元,成交金额3202万元,换手率0.66%,振幅5.86%,量比0.47。和誉-B今日主力资金净流入517万元,上一交易日主力净流出359万元。该股近5个交易日上涨16.32%,主力资金累计净流出575万元;近20日主力资金累计净流出1778万元,其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414170800a4584a2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414170800a4584a2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02256","BK1161"],"gpt_icon":0},{"id":"2518756257","title":"和誉-B午前涨超6% 机构指公司年内开始有望迎来密集收获","url":"https://stock-news.laohu8.com/highlight/detail?id=2518756257","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518756257?lang=zh_cn&edition=full","pubTime":"2025-03-11 11:55","pubTimestamp":1741665300,"startTime":"0","endTime":"0","summary":" 和誉-B午前上涨6.52%,现报7.84港元,成交额2590.26万港元。 中金发布研报称,由于和誉-B创新管线进展顺利,2025年开始有望迎来密集收获,该行上调2025年净利润预测65.7%至4,473万元,并引入2026年净利润预测3.2亿元。根据公司公告,依帕戈替尼220mg BID组在ICI和mTKIs经治的FGF19+HCC中ORR为44.8%,联合阿替利珠单抗治疗FGF19+HCC的ORR 为50%,该行认为单药及联用方案均体现亮眼的有效性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-03-11/doc-inepfzsr5624303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2488822045.USD","BK1161","02256"],"gpt_icon":0},{"id":"2518737756","title":"港股异动 | 和誉-B(02256)盘中涨超5% 机构指公司年内开始有望迎来密集收获 目前现金充裕","url":"https://stock-news.laohu8.com/highlight/detail?id=2518737756","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518737756?lang=zh_cn&edition=full","pubTime":"2025-03-11 10:24","pubTimestamp":1741659899,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,和誉-B盘中涨超5%,截至发稿,涨5.43%,报7.76港元,成交额1167.91万港元。中金发布研报称,由于和誉-B创新管线进展顺利,2025年开始有望迎来密集收获,该行上调2025年净利润预测65.7%至4,473万元,并引入2026年净利润预测3.2亿元。截至2024年末,公司现金及银行结余为19.59亿元,该行认为公司目前现金充裕,未来有望持续支持公司研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1260184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU2488822045.USD","02256"],"gpt_icon":0},{"id":"2518753262","title":"和誉-B盘中异动 股价大涨5.16%报7.740港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518753262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518753262?lang=zh_cn&edition=full","pubTime":"2025-03-11 10:21","pubTimestamp":1741659667,"startTime":"0","endTime":"0","summary":"2025年03月11日早盘10时21分,和誉-B股票出现波动,股价急速拉升5.16%。截至发稿,该股报7.740港元/股,成交量149.4万股,换手率0.22%,振幅7.34%。资金方面,该股资金流入484.286万港元,流出402.83万港元。最近的财报数据显示,该股实现营业收入5.44亿港元,净利润3,056.24万港元,每股收益0.0432港元,毛利5.44亿港元,市盈率172.11倍。和誉-B股票所在的生物技术行业中,整体涨幅为0.76%。该公司拥有两款核心候选产品ABSK011及ABSK091以及12款其他管线候选产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503111021079640d967&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503111021079640d967&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02256","BK1161","LU2488822045.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbisko.com","stockEarnings":[{"period":"1week","weight":0.0052},{"period":"1month","weight":-0.0955},{"period":"3month","weight":0.5913},{"period":"6month","weight":0.7796},{"period":"1year","weight":1.3242},{"period":"ytd","weight":0.6674}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":-0.0433},{"period":"3month","weight":0.0937},{"period":"6month","weight":0.0787},{"period":"1year","weight":0.2452},{"period":"ytd","weight":0.1027}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和誉开曼有限责任公司是一家中国的临床阶段生物制药公司。该公司致力于发现及开发创新且差异化的小分子肿瘤疗法。该公司拥有两款核心候选产品ABSK011及ABSK091以及12款其他管线候选产品。ABSK011是一种有效的高选择性小分子成纤维细胞生长因子受体4(FGFR4)抑制剂。ABSK091是一种分子靶向候选产品,是FGFR亚型1、2及3的高效及选择性抑制剂。该公司的产品主要用于治疗肝细胞癌(HCC)、尿路上皮癌(UC)及胃癌(GC)。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.143011},{"month":2,"riseRate":0.75,"avgChangeRate":0.046576},{"month":3,"riseRate":0.5,"avgChangeRate":0.054417},{"month":4,"riseRate":0.25,"avgChangeRate":-0.010041},{"month":5,"riseRate":0,"avgChangeRate":-0.043841},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.013147},{"month":7,"riseRate":0.666667,"avgChangeRate":0.049332},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.050943},{"month":9,"riseRate":0.666667,"avgChangeRate":0.042883},{"month":10,"riseRate":0.666667,"avgChangeRate":0.004984},{"month":11,"riseRate":0.75,"avgChangeRate":0.204437},{"month":12,"riseRate":0,"avgChangeRate":-0.093315}],"exchange":"SEHK","name":"和誉-B","nameEN":"ABBISKO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和誉-B(02256)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和誉-B,02256,和誉-B股票,和誉-B股票老虎,和誉-B股票老虎国际,和誉-B行情,和誉-B股票行情,和誉-B股价,和誉-B股市,和誉-B股票价格,和誉-B股票交易,和誉-B股票购买,和誉-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和誉-B(02256)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}